Market Overview
The Non-Hodgkin Lymphoma (NHL) therapeutics market is witnessing significant growth driven by the increasing incidence of NHL, advancements in targeted therapies, and rising awareness of treatment options. Non-Hodgkin lymphoma, a heterogeneous group of lymphoid malignancies, affects both adults and children, with symptoms ranging from painless lymph node enlargement to...